{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:39:41Z","timestamp":1767850781009,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ncl.2021.11.012","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:42:40Z","timestamp":1648705360000},"page":"405-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Familial Neoplastic Syndromes"],"prefix":"10.1016","volume":"40","author":[{"given":"Ryan G.","family":"Eaton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.ncl.2021.11.012_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib3","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, MD, USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib4","first-page":"vdz040","article-title":"Brain tumors in Neurofibromatosis type 1","volume":"1","author":"Costa","year":"2019","journal-title":"Neurooncol Adv"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.20211","article-title":"Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome","volume":"122a","author":"King","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib7","first-page":"747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"16","key":"10.1016\/j.ncl.2021.11.012_bib8","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1227\/01.NEU.0000298904.63635.2D","article-title":"Brainstem lesions in neurofibromatosis type 1","volume":"61","author":"Ullrich","year":"2007","journal-title":"Neurosurgery"},{"issue":"16","key":"10.1016\/j.ncl.2021.11.012_bib10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","article-title":"A\u00a0multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1","volume":"88","author":"Mahdi","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2021.11.012_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/PL00007285","article-title":"Cerebellar gliomas in children with NF1: pathology and surgery","volume":"16","author":"Vinchon","year":"2000","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2214\/ajr.159.1.1609692","article-title":"Evolution of white matter lesions in neurofibromatosis type 1: MR findings","volume":"159","author":"Sevick","year":"1992","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","article-title":"Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits","volume":"159","author":"Nguyen","year":"2011","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006123-199808000-00038","article-title":"Surgical management of spinal cord compression from plexiform neurofibromas in patients with neurofibromatosis 1","volume":"43","author":"Pollack","year":"1998","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib15","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"Ferner","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib18","first-page":"319","article-title":"Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors","volume":"126","author":"Watson","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"9679","key":"10.1016\/j.ncl.2021.11.012_bib19","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: a consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Br J Neurosurg"},{"issue":"11","key":"10.1016\/j.ncl.2021.11.012_bib21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/01.WNL.0000035638.74084.F4","article-title":"Evaluation of clinical diagnostic criteria for neurofibromatosis 2","volume":"59","author":"Baser","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib22","first-page":"1","article-title":"Acoustic neuroma","volume":"9","year":"1991","journal-title":"Consens Statement"},{"issue":"304","key":"10.1016\/j.ncl.2021.11.012_bib23","first-page":"603","article-title":"A\u00a0clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q\u00a0J Med"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00006123-199605000-00004","article-title":"The neuroimaging and clinical spectrum of neurofibromatosis 2","volume":"38","author":"Mautner","year":"1996","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00129492-200403000-00012","article-title":"Hearing changes after diagnosis in neurofibromatosis type 2","volume":"25","author":"Masuda","year":"2004","journal-title":"Otol Neurotol"},{"issue":"9","key":"10.1016\/j.ncl.2021.11.012_bib26","doi-asserted-by":"crossref","first-page":"e46132","DOI":"10.1371\/journal.pone.0046132","article-title":"Mechanisms of hearing loss in neurofibromatosis type 2","volume":"7","author":"Asthagiri","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib27","first-page":"109","article-title":"Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors","volume":"117","author":"Dirks","year":"2012","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006123-199704000-00007","article-title":"Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2","volume":"40","author":"Samii","year":"1997","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib29","first-page":"274","article-title":"Early proactive management of vestibular schwannomas in neurofibromatosis type 2","volume":"49","author":"Brackmann","year":"2001","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0090-3019(00)00174-9","article-title":"Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2","volume":"53","author":"Kida","year":"2000","journal-title":"Surg Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","article-title":"Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates","volume":"60","author":"Mathieu","year":"2007","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib32","first-page":"339","article-title":"[Neurofibromatosis type 2. Preliminary results of gamma knife radiosurgery of vestibular schwannomas]","volume":"46","author":"Roche","year":"2000","journal-title":"Neurochirurgie"},{"issue":"9","key":"10.1016\/j.ncl.2021.11.012_bib33","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp.74.9.1288","article-title":"Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis","volume":"74","author":"Rowe","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.ncl.2021.11.012_bib34","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnen\/60.10.994","article-title":"Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases","volume":"60","author":"Perry","year":"2001","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"suppl_4","key":"10.1016\/j.ncl.2021.11.012_bib35","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.ncl.2021.11.012_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/adc.81.6.496","article-title":"Paediatric presentation of type 2 neurofibromatosis","volume":"81","author":"Evans","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ncl.2021.11.012_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-804280-9.00007-X","article-title":"Inherited genetic syndromes and meningiomas","volume":"169","author":"Look","year":"2020","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3171\/spi.2005.2.5.0574","article-title":"Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?","volume":"2","author":"Dow","year":"2005","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1148\/radiology.218.2.r01fe40434","article-title":"Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype","volume":"218","author":"Patronas","year":"2001","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib40","first-page":"523","article-title":"Intramedullary ependymoma of the spinal cord","volume":"72","author":"McCormick","year":"1990","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","article-title":"Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients","volume":"14","author":"Plotkin","year":"2011","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib42","first-page":"204","article-title":"Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients","volume":"79","author":"Epstein","year":"1993","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00006123-199902000-00012","article-title":"Results of microsurgical treatment for intramedullary spinal cord ependymomas: analysis of 36 cases","volume":"44","author":"Hoshimaru","year":"1999","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib44","first-page":"590","article-title":"Spinal cord astrocytoma: pathological and treatment considerations","volume":"83","author":"Minehan","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2214\/ajr.165.4.7676998","article-title":"Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety","volume":"165","author":"Mautner","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"Pt 5","key":"10.1016\/j.ncl.2021.11.012_bib46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/brain\/awf115","article-title":"Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2","volume":"125","author":"Sperfeld","year":"2002","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2021.11.012_bib47","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","article-title":"Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2","volume":"141","author":"Bosch","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3 Pt 1","key":"10.1016\/j.ncl.2021.11.012_bib48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.43.3_Part_1.622","article-title":"Visual impairment in patients with neurofibromatosis 2","volume":"43","author":"Bouzas","year":"1993","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2021.11.012_bib49","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archderm.1997.03890480059008","article-title":"Skin abnormalities in neurofibromatosis 2","volume":"133","author":"Mautner","year":"1997","journal-title":"Arch Dermatol"},{"issue":"5112","key":"10.1016\/j.ncl.2021.11.012_bib50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","article-title":"A\u00a0genetic register for von Hippel-Lindau disease","volume":"33","author":"Maddock","year":"1996","journal-title":"J\u00a0Med Genet"},{"issue":"9374","key":"10.1016\/j.ncl.2021.11.012_bib52","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib53","first-page":"82","article-title":"The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease","volume":"98","author":"Wanebo","year":"2003","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.ncl.2021.11.012_bib54","first-page":"1055","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser","year":"2014","journal-title":"J\u00a0Neurosurg"},{"issue":"4 Suppl","key":"10.1016\/j.ncl.2021.11.012_bib55","first-page":"372","article-title":"Microsurgical resection of spinal cord hemangioblastomas","volume":"57","author":"Lonser","year":"2005","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib56","first-page":"106","article-title":"Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease","volume":"98","author":"Lonser","year":"2003","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.ncl.2021.11.012_bib57","first-page":"994","article-title":"Hemorrhage after particle embolization of hemangioblastomas: comparison of outcomes in spinal and cerebellar lesions","volume":"106","author":"Cornelius","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.ncl.2021.11.012_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/cns.15.22","article-title":"Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review","volume":"4","author":"Migliorini","year":"2015","journal-title":"CNS Oncol"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib59","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.10.FOCUS16361","article-title":"Image-guided stereotactic radiosurgery for treatment of spinal hemangioblastoma","volume":"42","author":"Pan","year":"2017","journal-title":"Neurosurg Focus"},{"issue":"9","key":"10.1016\/j.ncl.2021.11.012_bib60","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"18","key":"10.1016\/j.ncl.2021.11.012_bib61","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.1997.03540420057030","article-title":"Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease","volume":"277","author":"Manski","year":"1997","journal-title":"JAMA"},{"issue":"3 Pt 1","key":"10.1016\/j.ncl.2021.11.012_bib62","first-page":"659","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ncl.2021.11.012_bib63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ncl.2021.11.012_bib64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/088307380001501003","article-title":"Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients","volume":"15","author":"J\u00f3zwiak","year":"2000","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2021.11.012_bib65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3171\/2019.2.PEDS18661","article-title":"Intracranial aneurysms in patients with tuberous sclerosis complex: a systematic review","volume":"24","author":"Chihi","year":"2019","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","article-title":"Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"66","author":"Nabbout","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2021.11.012_bib68","series-title":"GeneReviews(\u00ae)","article-title":"Schwannomatosis","author":"Dhamija","year":"1993"},{"issue":"10","key":"10.1016\/j.ncl.2021.11.012_bib69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.ncl.2021.11.012_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","article-title":"Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome","volume":"30","author":"Amadou","year":"2018","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"10.1016\/j.ncl.2021.11.012_bib71","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer screening recommendations for individuals with Li-Fraumeni syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ncl.2021.11.012_bib72","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/197140091302600608","article-title":"Lhermitte-Duclos disease. A case report","volume":"26","author":"Giorgianni","year":"2013","journal-title":"Neuroradiol J"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1440-1673.2001.00933.x","article-title":"Lhermitte-Duclos disease associated with Cowden's syndrome: case report and literature review","volume":"45","author":"Murray","year":"2001","journal-title":"Australas Radiol"},{"issue":"3","key":"10.1016\/j.ncl.2021.11.012_bib74","first-page":"1","article-title":"Radiographic findings of dysplastic cerebellar Gangliocytoma (Lhermitte-Duclos Disease) in a woman with cowden syndrome: a case study and literature review","volume":"14","author":"Joo","year":"2020","journal-title":"J\u00a0Radiol Case Rep"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:21:18Z","timestamp":1760005278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0733861921001237"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.11.012","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Neoplastic Syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}